James S. Hanson - Net Worth and Insider Trading

James S. Hanson Net Worth

The estimated net worth of James S. Hanson is at least $192,698 dollars as of 2024-05-16. James S. Hanson is the General Counsel of G1 Therapeutics Inc and owns about 41,087 shares of G1 Therapeutics Inc (GTHX) stock worth over $192,698. Details can be seen in James S. Hanson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James S. Hanson has not made any transactions after 2023-01-05 and currently still holds the listed stock(s).

Transaction Summary of James S. Hanson

To

James S. Hanson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James S. Hanson owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Fortrea Holdings Inc (FTRE) .

Click here to see the complete history of James S. Hanson’s form 4 insider trades.

Insider Ownership Summary of James S. Hanson

Ticker Comapny Transaction Date Type of Owner
GTHX G1 Therapeutics Inc 2023-01-05 General Counsel
FTRE Fortrea Holdings Inc 2023-06-09 General Counsel

James S. Hanson Latest Holdings Summary

James S. Hanson currently owns a total of 1 stock. James S. Hanson owns 41,087 shares of G1 Therapeutics Inc (GTHX) as of January 5, 2023, with a value of $192,698.

Latest Holdings of James S. Hanson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GTHX G1 Therapeutics Inc 2023-01-05 41,087 4.69 192,698

Holding Weightings of James S. Hanson


James S. Hanson Form 4 Trading Tracker

According to the SEC Form 4 filings, James S. Hanson has made a total of 3 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 2,368 shares on January 5, 2023, which brought James S. Hanson around $13,071.

Insider Trading History of James S. Hanson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James S. Hanson Trading Performance

GuruFocus tracks the stock performance after each of James S. Hanson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James S. Hanson is -15.88%. GuruFocus also compares James S. Hanson's trading performance to market benchmark return within the same time period. The performance of stocks bought by James S. Hanson within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James S. Hanson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James S. Hanson

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.35
Relative Return to S&P 500(%) -17.73

James S. Hanson Ownership Network

Ownership Network List of James S. Hanson

No Data

Ownership Network Relation of James S. Hanson


James S. Hanson Owned Company Details

What does G1 Therapeutics Inc do?

Who are the key executives at G1 Therapeutics Inc?

James S. Hanson is the General Counsel of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .

G1 Therapeutics Inc (GTHX) Insider Trades Summary

Over the past 18 months, James S. Hanson made 1 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 2,368. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,059 shares made by Rajesh Malik , a net sale of 122,272 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,620 shares made by Terry L Murdock .

In summary, during the past 3 months, insiders sold 84,560 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 84,560 shares. During the past 18 months, 320,099 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 320,099 shares.

G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

G1 Therapeutics Inc Insider Transactions

No Available Data

James S. Hanson Mailing Address

Above is the net worth, insider trading, and ownership report for James S. Hanson. You might contact James S. Hanson via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.

Discussions on James S. Hanson

No discussions yet.